| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| DiaMedica Therapeutics Inc. | CFO and Secretary | Voting Common Shares, no par value per share | 32.3K | $90.4K | $2.80 | Jun 1, 2024 | Direct |
| DiaMedica Therapeutics Inc. | CFO and Secretary | Stock Option (right to buy) | 130K | Jun 1, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| DMAC | DiaMedica Therapeutics Inc. | Jun 1, 2024 | 1 | $0 | 4 | Jun 3, 2024 | CFO and Secretary |
| DMAC | DiaMedica Therapeutics Inc. | Jun 23, 2023 | 1 | $39.1K | 4 | Jun 26, 2023 | CFO and Secretary |
| DMAC | DiaMedica Therapeutics Inc. | Jun 1, 2023 | 1 | $0 | 4 | Jun 2, 2023 | CFO and Secretary |
| DMAC | DiaMedica Therapeutics Inc. | Jun 1, 2022 | 1 | $0 | 4 | Jun 2, 2022 | CFO and Secretary |
| DMAC | DiaMedica Therapeutics Inc. | Aug 16, 2021 | 1 | $31.5K | 4 | Aug 16, 2021 | CFO and Secretary |
| DMAC | DiaMedica Therapeutics Inc. | Jul 28, 2021 | 1 | $0 | 4 | Jul 29, 2021 | CFO and Secretary |